S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
NASDAQ:EMBC

Embecta (EMBC) Stock Forecast, Price & News

$15.17
-0.31 (-2.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$15.16
$15.61
50-Day Range
$15.17
$22.17
52-Week Range
$15.16
$36.64
Volume
488,284 shs
Average Volume
627,993 shs
Market Capitalization
$869.24 million
P/E Ratio
18.73
Dividend Yield
3.96%
Price Target
$16.00

Embecta MarketRank™ Forecast

Analyst Rating
Sell
1.00 Rating Score
Upside/​Downside
5.5% Upside
$16.00 Price Target
Short Interest
Bearish
7.72% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$409,371 Bought Last Quarter
Proj. Earnings Growth
-27.46%
From $2.84 to $2.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.36 out of 5 stars

Medical Sector

924th out of 968 stocks

Surgical & Medical Instruments Industry

85th out of 90 stocks


EMBC stock logo

About Embecta (NASDAQ:EMBC) Stock

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

EMBC Price History

EMBC Stock News Headlines

Embecta (NASDAQ:EMBC) Shares Gap Up Following Insider Buying Activity
Investing Legend Warns: NVIDIA is a "Delusion"
Irrational investment in this tech giant may have made it “too big to succeed” says this renowned expert. Read this before you buy shares.
Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15
Embecta Corporation (EMBC) Gets a Sell from Bank of America Securities
Embecta Corp (EMBC)
Investing Legend Warns: NVIDIA is a "Delusion"
Irrational investment in this tech giant may have made it “too big to succeed” says this renowned expert. Read this before you buy shares.
Embecta (NASDAQ: EMBC.V)
embecta to Participate in Investor Conferences
8-K: Embecta Corp.
BTIG Keeps Their Hold Rating on Embecta Corporation (EMBC)
Embecta: Q2 Earnings Insights
See More Headlines
Receive EMBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embecta and its competitors with MarketBeat's FREE daily newsletter.

EMBC Company Calendar

Last Earnings
8/08/2023
Ex-Dividend for 9/13 Dividend
8/24/2023
Dividend Payable
9/13/2023
Today
9/22/2023
Fiscal Year End
9/30/2023
Next Earnings (Estimated)
12/18/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EMBC
Fax
N/A
Employees
1,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.00
High Stock Price Forecast
$16.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+5.5%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

Net Income
$223.60 million
Pretax Margin
6.57%

Debt

Sales & Book Value

Annual Sales
$1.13 billion
Cash Flow
$5.29 per share
Book Value
($15.41) per share

Miscellaneous

Free Float
57,178,000
Market Cap
$869.24 million
Optionable
Optionable
Beta
0.49
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Devdatt Kurdikar (Age 55)
    Pres, CEO & Director
    Comp: $1.91M
  • Mr. Jacob P. Elguicze (Age 50)
    Sr. VP & CFO
    Comp: $971.06k
  • Mr. Jeffrey Z. Mann (Age 50)
    Sr. VP, Gen. Counsel, Head of Corp. Devel. & Corp. Sec.
    Comp: $910.73k
  • Mr. Shaun Curtis (Age 53)
    Sr. VP of Global Manufacturing & Supply Chain
    Comp: $691.46k
  • Mr. Brian R. Capone (Age 48)
    VP, Chief Accounting Officer & Corp. Controller
  • Ms. Colleen Riley (Age 58)
    Sr. VP & Chief Technology Officer
  • Mr. Pravesh Khandelwal
    VP & Head of Investor Relations
  • Ms. Ginny Blocki
    Sr. VP of Global Marketing & Product Management
  • Mr. Tom Blount (Age 49)
    Sr. VP & Pres of North America
  • Mr. Slobodan Radumilo (Age 52)
    Sr. VP & Pres of International













EMBC Stock - Frequently Asked Questions

Should I buy or sell Embecta stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Embecta in the last twelve months. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" EMBC shares.
View EMBC analyst ratings
or view top-rated stocks.

What is Embecta's stock price forecast for 2023?

1 equities research analysts have issued 12 month price targets for Embecta's stock. Their EMBC share price forecasts range from $16.00 to $16.00. On average, they expect the company's stock price to reach $16.00 in the next year. This suggests a possible upside of 5.5% from the stock's current price.
View analysts price targets for EMBC
or view top-rated stocks among Wall Street analysts.

How have EMBC shares performed in 2023?

Embecta's stock was trading at $25.29 at the start of the year. Since then, EMBC stock has decreased by 40.0% and is now trading at $15.17.
View the best growth stocks for 2023 here
.

Are investors shorting Embecta?

Embecta saw a increase in short interest in August. As of August 31st, there was short interest totaling 4,380,000 shares, an increase of 19.7% from the August 15th total of 3,660,000 shares. Based on an average trading volume of 648,100 shares, the days-to-cover ratio is currently 6.8 days. Currently, 7.7% of the company's stock are sold short.
View Embecta's Short Interest
.

When is Embecta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, December 18th 2023.
View our EMBC earnings forecast
.

How were Embecta's earnings last quarter?

Embecta Corp. (NASDAQ:EMBC) issued its earnings results on Tuesday, August, 8th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.23. The business had revenue of $286.10 million for the quarter, compared to the consensus estimate of $275.07 million. Embecta had a negative trailing twelve-month return on equity of 21.04% and a net margin of 4.24%. The business's revenue was down 1.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.07 earnings per share.

How often does Embecta pay dividends? What is the dividend yield for Embecta?

Embecta declared a quarterly dividend on Tuesday, August 8th. Shareholders of record on Friday, August 25th will be paid a dividend of $0.15 per share on Wednesday, September 13th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.96%. The ex-dividend date is Thursday, August 24th.
Read our dividend analysis for EMBC
.

What ETFs hold Embecta's stock?

ETFs with the largest weight of Embecta (NASDAQ:EMBC) stock in their portfolio include Invesco S&P Spin-Off ETF (CSD).Invesco S&P SmallCap Health Care ETF (PSCH).

Is Embecta a good dividend stock?

Embecta (NASDAQ:EMBC) pays an annual dividend of $0.60 per share and currently has a dividend yield of 3.81%. The dividend payout ratio is 74.07%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EMBC will have a dividend payout ratio of 29.13% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EMBC.

What guidance has Embecta issued on next quarter's earnings?

Embecta updated its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $2.75-$2.80 for the period, compared to the consensus earnings per share estimate of $1.69. The company issued revenue guidance of $1.11 billion-$1.11 billion, compared to the consensus revenue estimate of $1.11 billion.

What is Embecta's stock symbol?

Embecta trades on the NASDAQ under the ticker symbol "EMBC."

Who are Embecta's major shareholders?

Embecta's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (15.85%), Yacktman Asset Management LP (4.58%), State Street Corp (4.26%), Geode Capital Management LLC (2.06%), Krensavage Asset Management LLC (1.87%) and Bank of New York Mellon Corp (1.73%). Insiders that own company stock include David F Melcher, Devdatt Kurdikar, Jacob Elguicze and Jeffrey Z Mann.
View institutional ownership trends
.

How do I buy shares of Embecta?

Shares of EMBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Embecta's stock price today?

One share of EMBC stock can currently be purchased for approximately $15.17.

How much money does Embecta make?

Embecta (NASDAQ:EMBC) has a market capitalization of $869.24 million and generates $1.13 billion in revenue each year. The company earns $223.60 million in net income (profit) each year or $0.81 on an earnings per share basis.

How many employees does Embecta have?

The company employs 1,900 workers across the globe.

How can I contact Embecta?

The official website for the company is www.embecta.com. The company can be reached via phone at 201-847-6880 or via email at investor.relations@embecta.com.

This page (NASDAQ:EMBC) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -